¿ Puedo confiar en mis experimentos de SRM? PJ Navarro, L Espona Pernas, H Röst, L Malmström, R Aebersold Universidad de Córdoba, Servicio de Publicaciones, 2012 | | 2012 |
'Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle Washington, and Institute for Systems Biology, Seattle, Washington DB Martin, DR Gifford, ME Wright, A Keller, E Yi, DR Goodlett, ... Cancer Research 64, 347-355, 2004 | | 2004 |
" Personalized health": report to discuss options and frame for a new Swiss initiative R Aebersold, V Mooser, J Beckmann, M Dermitzakis, E Dorcey, M Kansy, ... Working Group, SystemsX. ch, 2014 | | 2014 |
[15] solid-phase sequencing of 32P-labeled phosphopeptides at picomole and subpicomole levels REH Wettenhall, RH Aebersold, LE Hood Methods in enzymology 201, 186-199, 1991 | 113 | 1991 |
10.1 Introduction Despite increased awareness and focus on cancer research in recent decades, mortality rates in some cancers still remain high. The development of biomarkers R Chen, TA Brentnall, R Aebersold Clinical Proteomics: From Diagnosis to Therapy, 2008 | | 2008 |
108. 2003 R Aebersold, M Mann Mass spectrometry-based proteomics. Nature 422, 198-207, 0 | 11 | |
1311 Quantitative analysis of Pten conditional knockout mouse proteome reveals significant prognostic biomarkers for survival in metastatic castration resistant prostate cancer … M Kaelin, IL Cima, R Schiess, PJ Wild, N Fankhauser, H Moch, ... EJC Supplements 2 (7), 142, 2009 | | 2009 |
318 The ATM-mediated DNA damage response: the system and the pathways Y Shiloh, Y Ziv, R Elkon, S Rashi-Elkeles, A Kuperstein, A Ben-Simon, ... ejc supplements 5 (8), 84, 2010 | | 2010 |
35: Personalised proteotypes and their association with disease R Aebersold European Journal of Cancer, S9-S10, 2014 | | 2014 |
4.8 Non DIA-quantification R Aebersold, O Kohlbacher, O Vitek Computational Mass Spectrometry, 13, 2014 | | 2014 |
4058 Enhanced efficiency of large-scale clinical proteomic studies: when less is more S Thomas, B Friedrich, M Schnaubelt, DW Chan, H Zhang, R Aebersold Journal of Clinical and Translational Science 4 (s1), 107-107, 2020 | | 2020 |
5 Towards a high throughput platform for quantitative serum protein profiling R Aebersold, X Li, E Yi, P Mallick, H Zhang EJC Supplements 8 (2), 3, 2004 | | 2004 |
66 [4] MASS SPECTROMETRY: MODIFIED PROTEINS AND GLYCOCONJUGATES GL CORTHALS, R AEBERSOLD, DR GOODLETT Mass Spectrometry: Modified Proteins and Glycoconjugates 405, 66, 2005 | | 2005 |
7q11. 23 CNV alters protein synthesis and REST-mediated neuronal intrinsic excitability M Mihailovich, PL Germain, R Shyti, D Pozzi, R Noberini, Y Liu, D Aprile, ... bioRxiv, 2022.10. 10.511483, 2022 | 1 | 2022 |
7th HUPO World Congress of Proteomics: Launching the Second Phase of the HUPO Plasma Proteome Project (PPP‐2) 16–20 August 2008, Amsterdam, The … GS Omenn, R Aebersold, YK Paik Proteomics 9 (1), 4-6, 2009 | 30 | 2009 |
A brain-specific activator of cyclin-dependent kinase 5 J Lew, QQ Huang, Z Qi, RJ Winkfein, R Aebersold, T Hunt, JH Wang Nature 371 (6496), 423-426, 1994 | 690 | 1994 |
A Candida albicans peptideatlas V Vialas, Z Sun, CVL y Penha, M Carrascal, J Abián, L Monteoliva, ... Journal of proteomics 97, 62-68, 2014 | 25 | 2014 |
A case for a human immuno-peptidome project consortium E Caron, R Aebersold, A Banaei-Esfahani, C Chong, ... Immunity 47 (2), 203-208, 2017 | 70 | 2017 |
A cellular gene encodes scrapie PrP 27-30 protein B Oesch, D Westaway, M Wälchli, MP McKinley, SBH Kent, R Aebersold, ... Cell 40 (4), 735-746, 1985 | 2034 | 1985 |
A class of environmental and endogenous toxins induces BRCA2 haploinsufficiency and genome instability SLW Tan, S Chadha, Y Liu, E Gabasova, D Perera, K Ahmed, ... Cell 169 (6), 1105-1118. e15, 2017 | 180 | 2017 |